Identification of potential tumor-educated platelets RNA biomarkers in non-small-cell lung cancer by integrated bioinformatical analysis

被引:26
|
作者
Xue, Linlin [1 ,2 ]
Xie, Li [2 ,3 ]
Song, Xingguo [3 ]
Song, Xianrang [2 ,3 ]
机构
[1] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Clin Lab, Jinan, Shandong, Peoples R China
[3] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Shandong Prov Key Lab Radiat Oncol, Jinan, Shandong, Peoples R China
关键词
biomarker; integrated bioinformatical analysis; RNA; spliceosome; tumor-educated platelets;
D O I
10.1002/jcla.22450
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BackgroundPlatelets have emerged as key players in tumorigenesis and tumor progression. Tumor-educated platelet (TEP) RNA profile has the potential to diagnose non-small-cell lung cancer (NSCLC). The objective of this study was to identify potential TEP RNA biomarkers for the diagnosis of NSCLC and to explore the mechanisms in alternations of TEP RNA profile. MethodsThe RNA-seq datasets GSE68086 and GSE89843 were downloaded from Gene Expression Omnibus DataSets (GEO DataSets). Then, the functional enrichment of the differentially expressed mRNAs was analyzed by the Database for Annotation Visualization and Integrated Discovery (DAVID). The miRNAs which regulated the differential mRNAs and the target mRNAs of miRNAs were identified by miRanda and miRDB. Then, the miRNA-mRNA regulatory network was visualized via Cytoscape software. ResultsTwenty consistently altered mRNAs (2 up-regulated and 18 down-regulated) were identified from the two GSE datasets, and they were significantly enriched in several biological processes, including transport and establishment of localization. Twenty identical miRNAs were found between exosomal miRNA-seq dataset and 229 miRNAs that regulated 20 consistently differential mRNAs in platelets. We also analyzed 13 spliceosomal mRNAs and their miRNA predictions; there were 27 common miRNAs between 206 differential exosomal miRNAs and 338 miRNAs that regulated 13 distinct spliceosomal mRNAs. ConclusionThis study identified 20 potential TEP RNA biomarkers in NSCLC for diagnosis by integrated bioinformatical analysis, and alternations in TEP RNA profile may be related to the post-transcriptional regulation and the splicing metabolisms of spliceosome.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] PD-L1 mRNA Derived from Tumor-Educated Platelets Predicts the Clinical Outcome of Immunotherapy in Non-Small Cell Lung Cancer
    Chang, J.
    Hu, Z.
    Sun, S.
    Yu, H.
    Wu, X.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S447 - S447
  • [22] Cancer diagnosis by machine learning-powered RNA-sequencing of tumor-educated platelets
    Berenguer, Jordi
    ONCOGENE, 2019, 38 : 8 - 8
  • [23] Clinical utility and diagnostic value of tumor-educated platelets in lung cancer: a systematic review and meta-analysis
    Wiyarta, Elvan
    Nugraha, Darrin Ananda
    Ramadani, Muhammad Indera
    Gustya, Gita Fajri
    Ammar, Muhammad Farrasy
    Edwar, Hana Dzakira
    Kheirizzad, Nildza
    Mukhlisah, Mutiah Nurul
    Burhan, Erlina
    Syahruddin, Elisna
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Identification and Validation of Long Noncoding RNA Biomarkers in Human Non-Small-Cell Lung Carcinomas
    Yu, Hui
    Xu, Qinghua
    Liu, Fang
    Ye, Xun
    Wang, Jialei
    Meng, Xia
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 645 - 654
  • [25] Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
    Passaro, A.
    Palazzo, A.
    Trenta, P.
    Mancini, M. L.
    Morano, F.
    Cortesi, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (22) : 3689 - 3700
  • [26] Tumor evolution in non-small-cell lung cancer
    Parry, Marina
    ESMO OPEN, 2018, 3 (06)
  • [27] The Tumor Microenvironment in Non-Small-Cell Lung Cancer
    Graves, Edward E.
    Maity, Amit
    Le, Quynh-Thu
    SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (03) : 156 - 163
  • [28] Detection and Identification of Potential Biomarkers of Non-small Cell Lung Cancer
    Yang, Yang
    Zhao, Song
    Fan, Yuxia
    Zhao, Feng
    Liu, Quan
    Hu, Wei
    Liu, Donglei
    Fan, Kai
    Wang, Jiaxiang
    Wang, Jianjun
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (06) : 455 - 465
  • [29] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
  • [30] Biomarkers of response to gefitinib in non-small-cell lung cancer
    David P Carbone
    Nature Clinical Practice Oncology, 2004, 1 : 66 - 67